PathGroup attracts private equity investment to fuel M&A, Texas expansion

PathGroup, one of the largest independent labs in the U.S., has formed an investment partnership with private equity firm GTCR.

Advertisement

GTCR made a majority investment in the company, the companies said May 13. As part of the deal, former Labcorp CEO and chairman Dave King is joining PathGroup’s board as chairman. 

The investment is intended to support PathGroup’s expansion into Texas and other areas, as well as mergers and acquisitions.

The terms of the transaction were not disclosed.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.